Stocks seesawed in the final hour of trading after House leaders pulled an unpopular health care bill just minutes before an expected vote. Republicans' Obamacare replacement did not have the needed votes to pass. This is a blowback to President Trump who touted his negotiation skills on the campaign trail. Finish Line (FINL) slumped after a disappointing quarter. The shoe retailer swung to a loss, while same-store sales fell nearly 5%. Margins increased on higher promotional activity. Crude oil prices moved higher despite another weekly increase in the number of active oil rigs in the U.S. Crude has been under pressure on signs of ballooning U.S. supply and increasing production overseas. Under Armour (UA) was upgraded to buy at Jefferies. The company was also added to the Franchise Picks list. The brand has strengthened over time and industry demand is robust, Jefferies said.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.